Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-27

Clinical Trial Update: Mexiletine for the Treatment of Muscle Cramps in ALS [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating mexiletine for reducing muscle cramps in amyotrophic lateral sclerosis completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mexitil (mexiletine) (mexiletine)

Snippet

Sponsor: Bjorn Oskarsson, MD | Conditions: Muscle Cramps in Amyotrophic Lateral Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2017-06-27